Results 121 to 130 of about 15,888 (236)

RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: Immune regulation by vasoactive intestinal peptide

open access: yes, 2011
Supported by the Instituto de Salud Carlos III (grant PI080025 and RETICS Program grant RD08/0075, RIER) within VI PNDE I D I 2008/2011, by FEDER, and by Universidad Complutense de Madrid–Banco Santander Central Hispano (grant GR58/08)Objective The aim ...
Rebeca Jimeno   +13 more
core   +1 more source

Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome

open access: yesGut and Liver, 2016
Background/AimsPrevious studies have revealed that mast cells (MCs) may activate the protease-activated receptors and release of neuropeptides involved in the pathogenesis of irritable bowel syndrome (IBS).
doaj   +1 more source

Vasoactive intestinal peptide influences hatching of ovine blastocysts

open access: yes, 2000
Expanded blastocysts collected from superovulated Sarda ewes were divided at random into four groups for culture in a simple medium that does not support blastocyst hatching (CZB) or a complex medium that is permissive to hatching (TCM 199), with or ...
LEDDA, Sergio   +4 more
core   +1 more source

Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells

open access: yes
Financiado con el Fondo Europeo de Desarrollo Regional (FEDER)Several neuropeptides present in bone tissues, produced by nerve fibers and bone cells, have been reported to play a role in regulating the fine-tuning of osteoblast and osteoclast functions ...
Arribas Castaño, Paula   +12 more
core   +1 more source

Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors

open access: yes, 2010
BACKGROUND AND PURPOSE Vasoactive intestinal peptide is expressed in the respiratory tract and induces its effects via its receptors, VPAC1 and VPAC2. RO5024118 is a selective VPAC2 receptor agonist derived via chemical modification of an earlier VPAC2 ...
Gardiner P   +58 more
core   +1 more source

Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.

open access: yes, 1982
The presence of receptors, recognized by vasoactive intestinal peptide (VIP) as well as by PHI (a peptide with N-terminal histidine and C-terminal isoleucine amide), was documented in lung membranes from rat, mouse, guinea pig and man by the ability of ...
Heuse, Danielle   +9 more
core   +1 more source

Development of Simplified Vasoactive Intestinal Peptide Analogs with Receptor Selectivity and Stability for Human Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-Activating Polypeptide Receptors

open access: yes, 2020
Vasoactive intestinal peptide (VIP) is a widespread neurotransmitter whose physiological and pathophysiological actions are mediated by two receptor classes, VIP/pituitary adenylate cyclase-activating polypeptide (VPAC) 1 and VPAC 2 .
Robert T Jensen   +6 more
core  

Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine

open access: yes, 2017
Vasoactive intestinal peptide (VIP) is an endogenous neuropeptide with a broad array of physiological functions in many organs including the intestine. Its actions are mediated via G protein-coupled receptors, and vasoactive intestinal peptide receptor ...
Waddah A. Alrefai   +17 more
core   +1 more source

Role of G protein-coupled vasoactive intestinal peptide receptors in HIV integration

open access: yes, 2011
The pathogenesis of HIV infection is closely linked to the replication of the virus in vivo. Even though the progress in anti-HIV-1 chemotherapy in the past several years has been dramatic, the efficient protection against HIV-1 infection still remains ...
Donald R Branch
core   +1 more source

Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: Effect of vasoactive intestinal peptide

open access: yes, 2011
This work was supported by grants PI080025, RETICS Program, RD08/0075 (RIER) from the Instituto de Salud Carlos III (ISCIII), within VI PNDE IRDRI 2008/2011 and by FEDER funds, GR58/08 from UCM-BSCH and a predoctoral fellowship from the Ministerio de ...
Mar Carrión   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy